XML 29 R8.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash flows from operating activities    
Net income $ 5,068 $ 3,102
Adjustments to reconcile net income to net cash provided by operating activities:    
Net (discount accretion) premium amortization (664) 69
Depreciation and amortization expense 1,388 1,079
Provision for loan losses 925 400
Share-based compensation 525 499
Gain on sales of loans originated for sale (1,216) (350)
Mortgage loans originated for sale (20,851) (16,682)
Proceeds from sales of loans originated for sale 23,185 15,505
Gain on sale of portfolio loans (1,878) 0
Net loss on disposal of premises and equipment 1 130
Deferred income taxes 1,024 211
Investment securities losses (gains) 40 (339)
Income from life insurance (540) (342)
Increase in accrued interest receivable (657) (413)
Decrease in accrued interest payable and other liabilities (352) (2,351)
Other, net (1,567) (89)
Net cash provided by operating activities 4,431 429
Cash flows from investing activities    
Proceeds from sales of AFS securities 0 59,464
Maturities, repayments and calls of AFS securities 20,497 6,306
Purchases of AFS securities (26,692) (85,324)
Net redemptions of restricted investments in bank stocks 361 550
Net increase in loans (31,515) (17,974)
Proceeds from sales of portfolio loans 21,618 0
Purchases of bank premises and equipment (83) (689)
Net cash used in investing activities (15,814) (37,667)
Cash flows from financing activities    
Net increase in deposits 21,746 61,931
Net decrease in borrowings with original maturities less than 90 days (65,716) (29,490)
Proceeds from FHLB advances 99,977 20,000
Payments on FHLB advances (40,098) (25,094)
Subordinated note issuance costs 0 (58)
Dividends paid (1,906) (1,413)
Acquisition of treasury stock (1,510) 0
Treasury shares repurchased for employee taxes associated with restricted stock vesting 0 (294)
Proceeds from issuance of stock for option exercises and employee stock purchase plan 64 58
Net cash provided by financing activities 12,557 25,640
Net increase (decrease) in cash and cash equivalents 1,174 (11,598)
Cash and cash equivalents at beginning of period 55,963 88,815
Cash and cash equivalents at end of period 57,137 77,217
Cash paid during the period for:    
Interest 5,544 4,724
Supplemental schedule of noncash investing activities:    
OREO acquired in settlement of loans 0 161
Lease liabilities arising from obtaining ROU assets 0 8,115
Securities purchases not yet settled $ 714 $ 0